BridgeBio Oncology Therapeutics, Inc. (BBOT)
Data as of , from SEC Form 4 filings.
No open-market insider trades (90d)Watch BBOT
See up to 3 months of BBOT. The 7-day demo opens the 1M and 3M ranges and puts BBOT on your watchlist.
Start 7-day demoLatest BBOT insider trades
- Marc Cobo - OfficerTax withholding / forfeiture$496
Idan Elmelech - OfficerTax withholding / forfeiture$1K- Pedro Beltran - Officer
About BridgeBio Oncology Therapeutics, Inc. (BBOT)
BridgeBio Oncology Therapeutics, Inc. files with the SEC under CIK 0001869105 and is classified as pharmaceutical preparations. It is grouped with Health Care companies on this site.
BBOT Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 2 | 52,738 | |
| Tax withholding / forfeiture | 5 | 2,766 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
BBOT insider transactions (Form 4)
3843 Form 4 filings on record, the earliest from Aug 11, 2025, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Marc Cobo - Officer | Tax withholding / forfeiture | Common Stock | 126 footnote F1 | $3.94 | $496 | |
| ||||||
| Idan Elmelech - Officer | Tax withholding / forfeiture | Common Stock | 343 footnote F1 | $3.94 | $1K | |
| ||||||
| Pedro Beltran - Officer | Tax withholding / forfeiture | Common Stock | 1,047 footnote F1 | $3.94 | $4K | |
| ||||||
| Yong Ben - Officer | Tax withholding / forfeiture | Common Stock | 1,047 footnote F1 | $3.94 | $4K | |
| ||||||
| Marc Cobo - Officer | Grant or award | Common Stock | 9,038 footnote F1 | $0.00 | - | |
| Marc Cobo - Officer | Tax withholding / forfeiture | Common Stock | 203 footnote F2 | $5.52 | $1K | |
| Marc Cobo - Officer | Grant or award | Stock Option (Right to Buy) | 43,700 | $0.00 | - | |
| ||||||
| Marc Cobo - Officer | Tax withholding / forfeiture | Common Stock | 125 footnote F1 | $7.80 | $975 | |
| ||||||
| Idan Elmelech - Officer | Tax withholding / forfeiture | Common Stock | 343 footnote F1 | $7.80 | $3K | |
| ||||||
| Yong Ben - Officer | Tax withholding / forfeiture | Common Stock | 1,047 footnote F1 | $7.80 | $8K | |
| ||||||
| Pedro Beltran - Officer | Tax withholding / forfeiture | Common Stock | 1,047 footnote F1 | $7.80 | $8K | |
| ||||||
 Bihua Chen - Director | Other | Common Stock | 4,528,186 | $0.00 | - | |
| Bihua Chen - Director | Other | Common Stock | 2,692,459 | $0.00 | - | |
| Bihua Chen - Director | Other | Common Stock | 1,704,862 | $0.00 | - | |
| Bihua Chen - Director | Other | Common Stock | 130,865 | $0.00 | - | |
| Praveen P. Tipirneni | Grant or award | Stock Option (Right to Buy) | 31,675 | $0.00 | - | |
 Frank McCormick | Grant or award | Stock Option (Right to Buy) | 31,675 | $0.00 | - | |
| Peter F. Lebowitz | Grant or award | Stock Option (Right to Buy) | 7,289 | $0.00 | - | |
 Raymond J. Kelleher | Grant or award | Stock Option (Right to Buy) | 31,675 | $0.00 | - | |
| Bihua Chen | Grant or award | Stock Option (Right to Buy) | 31,675 | $0.00 | - | |
| Jake Bauer | Grant or award | Stock Option (Right to Buy) | 31,675 | $0.00 | - | |
| Neil Kumar | Grant or award | Stock Option (Right to Buy) | 31,675 | $0.00 | - | |
| Idan Elmelech - Officer | Grant or award | Stock Option (Right to Buy) | 758,222 | $0.00 | - | |
| Pedro Beltran - Officer | Grant or award | Stock Option (Right to Buy) | 1,103,837 | $0.00 | - | |
| Yong Ben - Officer | Tax withholding / forfeiture | Common Stock | 1,047 footnote F1 | $9.03 | $9K | |
| ||||||
| Pedro Beltran - Officer | Tax withholding / forfeiture | Common Stock | 1,047 footnote F1 | $9.03 | $9K | |
| ||||||
| Uneek Mehra | Tax withholding / forfeiture | Common Stock | 524 footnote F1 | $9.03 | $5K | |
| ||||||
| Peter F. Lebowitz | Grant or award | Stock Option (Right to Buy) | 63,350 | $0.00 | - | |
| Uneek Mehra - Officer | Grant or award | Common Stock | 23,330 footnote F1 | $0.00 | - | |
| Uneek Mehra - Officer | Grant or award | Stock Option (Right to Buy) | 105,000 | $0.00 | - | |
| ||||||
| Pedro Beltran - Officer | Grant or award | Common Stock | 46,670 footnote F1 | $0.00 | - | |
| Pedro Beltran - Officer | Grant or award | Stock Option (Right to Buy) | 210,000 | $0.00 | - | |
| ||||||
| Yong Ben - Officer | Grant or award | Common Stock | 46,670 footnote F1 | $0.00 | - | |
| Yong Ben - Officer | Grant or award | Stock Option (Right to Buy) | 210,000 | $0.00 | - | |
| ||||||
 Eli M. Wallace - Officer | Grant or award | Stock Option (Right to Buy) | 1,114,400 | $0.00 | - | |
| Eli M. Wallace - Officer | Derivative | Stock Option (Right to Buy) | 1,114,400 | - footnote F2 | - | |
| ||||||
| BridgeBio Pharma LLC | Other | Common Stock | 784,720 | - footnote F1 | - | |
| ||||||
| Eli M. Wallace - Officer | Grant or award | Stock Option (Right to Buy) | 1,614,400 | $0.00 | - | |
Item 8.01, 9.01
Item 2.02, 9.01
Item 5.02, 5.07
Item 2.02, 9.01
BBOT insider trading FAQ
What is the latest insider trade for BBOT?
BridgeBio Oncology Therapeutics, Inc. (BBOT) had 5 insider filings in the last 90 days, with the most recent on 2026-10-05. The full record for BBOT runs to 43 Form 4 filings, the earliest from 2025-08-11. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying BBOT stock?
No insider purchases of BBOT were filed in the last 90 days.
How many insiders are selling BBOT stock?
No insider sales of BBOT were filed in the last 90 days.
Where can I see BBOT SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects BBOT Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Marc Cobo view on EDGAR
- - Idan Elmelech view on EDGAR
- - Pedro Beltran view on EDGAR
- - Yong Ben view on EDGAR
- - Marc Cobo view on EDGAR
- - Marc Cobo view on EDGAR
- - Idan Elmelech view on EDGAR
- - Yong Ben view on EDGAR
- - Pedro Beltran view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where BBOT's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow BBOT with a 7-day demo
- BBOT on your watchlist
- Every BBOT Form 4 filing on record
- Up to 3 months of BBOT price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
